Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Science (New York, N.Y.)
|
September 13, 1996
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
M Spina, E Merlo-Pich, R K Chan, et al.
Gene Therapy
|
February 4, 1999
Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor
P Ghersa, R P Gobert, P Sattonnet-Roche, et al.
Neuroreport
|
November 26, 1999
Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion
N le Novère, M Zoli, C Léna, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 1, 1995
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
E Merlo Pich, M Lorang, M Yeganeh, et al.
Stroke
|
February 1, 1992
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats
E Merlo Pich, R Grimaldi, M Zoli, et al.
Journal of Cardiothoracic Surgery
|
August 4, 2016
Outcomes following emergent open repair for thoracic aortic dissection are improved at higher volume centers in direct admissions and transfers
Aurelie E Merlo, Dhaval Chauhan, Chris Pettit, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1996
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats
F Rodríguez de Fonseca, P Rubio, F Menzaghi, et al.
Acta Physiologica Scandinavica. Supplementum
|
January 1, 1984
Studies on aging processes
L F Agnati, K Fuxe, F Benfenati, et al.
Neurochemistry International
|
May 28, 2010
Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol
L F Agnati, K Fuxe, M Ruggeri, et al.
Advances and Technical Standards in Neurosurgery
|
January 1, 1988
Regeneration in the central nervous system: concepts and facts
L F Agnati, I Zini, M Zoli, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Science (New York, N.Y.)
|
September 13, 1996
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
M Spina, E Merlo-Pich, R K Chan, et al.
Gene Therapy
|
February 4, 1999
Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor
P Ghersa, R P Gobert, P Sattonnet-Roche, et al.
Neuroreport
|
November 26, 1999
Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion
N le Novère, M Zoli, C Léna, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 1, 1995
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
E Merlo Pich, M Lorang, M Yeganeh, et al.
Stroke
|
February 1, 1992
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats
E Merlo Pich, R Grimaldi, M Zoli, et al.
Journal of Cardiothoracic Surgery
|
August 4, 2016
Outcomes following emergent open repair for thoracic aortic dissection are improved at higher volume centers in direct admissions and transfers
Aurelie E Merlo, Dhaval Chauhan, Chris Pettit, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1996
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats
F Rodríguez de Fonseca, P Rubio, F Menzaghi, et al.
Acta Physiologica Scandinavica. Supplementum
|
January 1, 1984
Studies on aging processes
L F Agnati, K Fuxe, F Benfenati, et al.
Neurochemistry International
|
May 28, 2010
Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol
L F Agnati, K Fuxe, M Ruggeri, et al.
Advances and Technical Standards in Neurosurgery
|
January 1, 1988
Regeneration in the central nervous system: concepts and facts
L F Agnati, I Zini, M Zoli, et al.
Page
of 9